FEATURED NEWS
NEWS: ACUITAS CO-AUTHORS STUDY THAT SHOWS PROMISE FOR A UNIVERSAL MRNA FLU SHOT (NOV 2022)
A new study co-authored by scientists from the University of Pennsylvania and Acuitas Therapeutics shows early promise for an mRNA vaccine targeting all known flu strains. Read about it here.
NEWS: ACUITAS RECEIVES LIFE SCIENCES BC'S COMPANY OF THE YEAR AWARD (SEP 2022)
Acuitas Therapeutics has been recognized as the 2022 Company of the Year by Life Sciences BC. Read about it here.
NEWS: ACUITAS PRESIDENT & CEO NAMED PACIFIC WINNER IN EY ENTREPRENEUR OF THE YEAR AWARD PROGRAM (JUL 2022)
Dr. Thomas Madden has been named as one of seven Pacific winners in the EY Entrepreneur of the Year Award Program. Read about it here.